tiprankstipranks
Trending News
More News >
Sino-Life Group Limited (HK:8296)
:8296
Hong Kong Market
Advertisement

Sino-Life Group Limited (8296) AI Stock Analysis

Compare
0 Followers

Top Page

HK:8296

Sino-Life Group Limited

(8296)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 4o)
Rating:48Neutral
Price Target:
HK$0.50
▲(25.00% Upside)
The overall stock score of 48 reflects significant financial challenges, including consistent losses and weak cash flows. Technical indicators show a bearish trend, and valuation metrics are poor due to negative earnings. The company's stable equity position provides some support, but strategic improvements are necessary for future growth.
Positive Factors
Revenue Growth
The company has experienced a revenue growth rate of over 15%, indicating a positive trend in expanding its market reach and customer base.
Equity Position
A strong equity position provides financial stability, allowing the company to withstand economic fluctuations and invest in growth opportunities.
Gross Profit Margin
Stable gross profit margins suggest effective cost management and pricing strategies, supporting long-term profitability potential.
Negative Factors
Consistent Losses
Ongoing net losses highlight challenges in achieving profitability, which could hinder long-term financial health and investment capacity.
Weak Cash Flow
Weak cash flow and negative free cash flow signal potential liquidity issues, limiting the company's ability to fund operations and growth.
Operational Inefficiencies
Weak EBIT and EBITDA margins indicate inefficiencies that could affect competitiveness and profitability, requiring strategic improvements.

Sino-Life Group Limited (8296) vs. iShares MSCI Hong Kong ETF (EWH)

Sino-Life Group Limited Business Overview & Revenue Model

Company DescriptionSino-Life Group Limited (8296) is a diversified investment holding company based in Hong Kong, primarily engaged in the life insurance and financial services sectors. The company operates through various subsidiaries, offering a range of products and services, including life insurance policies, health insurance, and other financial solutions tailored to meet the needs of individual and corporate clients. Sino-Life aims to provide comprehensive and innovative financial protection and investment options to its customers.
How the Company Makes MoneySino-Life Group Limited generates revenue primarily through the sale of life and health insurance policies, which includes premium collections from its clients. The company's revenue model is built on earning premiums from policyholders, which are then invested to generate additional income. Key revenue streams include individual life insurance products, group insurance plans, and supplementary health insurance. Additionally, the company may benefit from investment income derived from its managed assets. Strategic partnerships with financial institutions and distribution channels also enhance its market reach and contribute to revenue growth.

Sino-Life Group Limited Financial Statement Overview

Summary
Sino-Life Group Limited is facing financial challenges with consistent losses and weak cash flows. While the company's equity position provides some stability, operational inefficiencies and liquidity issues pose risks. Strategic improvements in profitability and cash management are necessary for long-term sustainability.
Income Statement
45
Neutral
The company shows fluctuating revenue with a slight increase in 2024. However, the net income is negative, indicating ongoing losses. Gross profit margin remains stable, but EBIT and EBITDA margins are weak, reflecting operational inefficiencies.
Balance Sheet
60
Neutral
The balance sheet shows a healthy equity ratio but also a notable level of debt, which is a concern. The company maintains a good cash position, but the return on equity is negative due to net losses.
Cash Flow
40
Negative
Cash flow from operations is weak, with negative free cash flow indicating potential liquidity issues. The company needs to improve its cash generation capabilities to support operations and reduce financial risk.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue76.60M74.94M72.57M77.97M72.86M68.34M
Gross Profit33.52M32.28M33.48M39.80M37.98M29.17M
EBITDA-3.57M-4.96M1.70M11.96M-4.28M7.40M
Net Income-4.84M-8.70M-7.17M-847.00K-9.87M-2.97M
Balance Sheet
Total Assets250.66M250.63M271.71M284.79M263.85M277.61M
Cash, Cash Equivalents and Short-Term Investments149.92M148.63M173.51M180.59M156.13M158.11M
Total Debt28.23M29.68M37.43M27.90M33.49M38.83M
Total Liabilities151.21M147.09M163.17M153.97M158.27M165.89M
Stockholders Equity119.70M123.45M123.72M113.22M114.61M119.27M
Cash Flow
Free Cash Flow1.19M-8.97M-3.04M7.77M-4.31M14.18M
Operating Cash Flow1.94M-8.21M-2.60M10.24M-407.00K17.89M
Investing Cash Flow-3.93M-3.30M17.36M-32.20M-1.83M-3.50M
Financing Cash Flow-3.07M-2.10M-7.66M18.77M-7.75M-6.17M

Sino-Life Group Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.40
Price Trends
50DMA
0.38
Negative
100DMA
0.41
Negative
200DMA
0.41
Negative
Market Momentum
MACD
-0.01
Positive
RSI
35.52
Neutral
STOCH
44.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8296, the sentiment is Negative. The current price of 0.4 is above the 20-day moving average (MA) of 0.38, above the 50-day MA of 0.38, and below the 200-day MA of 0.41, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 35.52 is Neutral, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8296.

Sino-Life Group Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
HK$319.88M11.522.99%8.27%-7.05%-43.44%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
61
Neutral
$6.86B-34.05-3.58%19.02%-28.00%-129.57%
55
Neutral
HK$480.00M-65.75-3.06%1.10%-38.66%-161.86%
48
Neutral
HK$34.49M-3.96%15.60%62.35%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8296
Sino-Life Group Limited
0.37
0.04
14.06%
HK:1448
Fu Shou Yuan International Group
2.91
-0.39
-11.74%
HK:0922
Anxian Yuan China Holdings Limited
0.13
-0.01
-7.14%
HK:6966
China Wan Tong Yuan (Holdings) Ltd.
0.50
-0.06
-10.71%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 12, 2025